Order Article Reprints

Krapež G, Šamec N, Zottel A, Katrašnik M, Kump A, Šribar J, Križaj I, Stojan J, Romih R, Bajc G, et al. In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting. Antibodies. 2025; 14(1):8. https://doi.org/10.3390/antib14010008

Krapež, Gloria, Neja Šamec, Alja Zottel, Mojca Katrašnik, Ana Kump, Jernej Šribar, Igor Križaj, Jurij Stojan, Rok Romih, Gregor Bajc, and et al. 2025. "In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting" Antibodies 14, no. 1: 8. https://doi.org/10.3390/antib14010008

Krapež, G., Šamec, N., Zottel, A., Katrašnik, M., Kump, A., Šribar, J., Križaj, I., Stojan, J., Romih, R., Bajc, G., Butala, M., Muyldermans, S., & Jovčevska, I. (2025). In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting. Antibodies, 14(1), 8. https://doi.org/10.3390/antib14010008